SCHEMBL3596461

SCHEMBL3596461

NC(=O)c1cccc(-c2cc(-c3nnn[nH]3)c(-c3cccc(C(N)=O)c3)s2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 3/20 0.41
HSD17B2 P37059 2/20 0.41
PRF1 P14222 2/20 0.41
PFKFB3 Q16875 1/20 0.40
MAP3K8 P41279 1/20 0.40
PRKCI P41743 1/20 0.39
IKBKB O14920 1/20 0.38
MAP2K4 P45985 2/20 0.38
TTK P33981 1/20 0.38
FYN P06241 2/20 0.38
EGFR P00533 2/20 0.37
CCNT1 O60563 1/20 0.37
CCND1 P24385 1/20 0.37
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
CDK7 P50613 1/20 0.37
CDK9 P50750 1/20 0.37
CCNH P51946 1/20 0.37
MNAT1 P51948 1/20 0.37
CDK6 Q00534 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3606907 0.89 HDAC1 (0.44) HSD17B1HSD17B2IKBKBMAP2K4EGFR
SCHEMBL3595152 0.86 PRF1 (0.42) PRF1MAP3K8MAP2K4CCNCCDK8
SCHEMBL3613513 0.82 ALDH1A1 (0.41) PRF1
SCHEMBL3065165 0.82 PARP1 (0.46) PRKCIMAP2K4TTKFYNEGFR
SCHEMBL3596099 0.81 HSD17B1 (0.64) HSD17B1HSD17B2
Hydrochloric Acid SCHEMBL12469361 0.81 MAP2K4 (0.45) PRKCIMAP2K4TTKFYNEGFR
SCHEMBL3607451 0.78 ESR1 (0.41) HSD17B1MAP2K4MAPK1CSNK2A1
SCHEMBL3601027 0.76 HDAC6 (0.41) HSD17B1HSD17B2IKBKBMAPK1DYRK1A
SCHEMBL12497225 0.75 ALDH1A1 (0.41) ITK
SCHEMBL3604357 0.74 ESR1 (0.61) HSD17B1HSD17B2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 HSD17B1 3041/4885HSD17B2 3760/4885PRF1 2604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.